YC-1 Inhibits VEGF and Inflammatory Mediators Expression on Experimental Central Retinal Vein Occlusion in Rhesus Monkey

References

• Pe’er J, Folberg R, Itin A, Gnessin H, Hemo I, Keshet E. Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology 1998;105(3):412–16.
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Sonoda KH, Sugahara M, Mochizuki Y, Enaida H, Oshima Y, Ueno A, Hata Y, Yoshida H, Ishibashi T. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One 2009;4(12):e8158.
   PubMed Web of Science ®Google Scholar
• Tah V, Orlans HO, Hyer J, Casswell E, Din N, Sri Shanmuganathan V, Ramskold L, Pasu S. Anti-VEGF Therapy and the Retina: an Update. J Ophthalmol 2015;2015:627674.
   PubMed Web of Science ®Google Scholar
• Ashraf M, Souka AA. Steroids in central retinal vein occlusion: is there a role in current treatment practice? J Ophthalmol 2015;2015:594615.
   PubMed Web of Science ®Google Scholar
• Ehlken C, Grundel B, Michels D, Junker B, Stahl A, Schlunck G, Hansen LL, Feltgen N, Martin G, Agostini HT, et al. Increased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion. PLoS One 2015;10(5):e0126859.
   PubMed Web of Science ®Google Scholar
• Hoh AE, Schaal KB, Dithmar S. [Central and branch retinal vein occlusion. Current strategies for treatment in Germany, Austria and Switzerland]. Ophthalmologe: Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft. 2007;104(4):290–94.
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Freund KB, Peiretti E, Cooney MJ, Ferrara DC, Yannuzzi LA. Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina 2007;27(4):426–31.
   PubMed Web of Science ®Google Scholar
• Smithen LM, Ober MD, Maranan L, Spaide RF. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 2004;138(5):740–43.
   PubMed Web of Science ®Google Scholar
• Thompson JT. Cataract formation and other complications of intravitreal triamcinolone for macular edema. Am J Ophthalmol 2006;141(4):629–37.
   PubMed Web of Science ®Google Scholar
• Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992;12(12):5447–54.
   PubMed Web of Science ®Google Scholar
• Huang LE, Arany Z, Livingston DM, Bunn HF. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 1996;271(50):32253–59.
   PubMed Web of Science ®Google Scholar
• Gleadle JM, Ratcliffe PJ. Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: evidence against a regulatory role for Src kinase. Blood 1997;89(2):503–09.
   PubMed Web of Science ®Google Scholar
• Jiang BH, Rue E, Wang GL, Roe R, Semenza GL. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 1996;271(30):17771–78.
   PubMed Web of Science ®Google Scholar
• Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996;16(9):4604–13.
   PubMed Web of Science ®Google Scholar
• Ozaki H, Yu AY, Della N, Ozaki K, Luna JD, Yamada H, Hackett SF, Okamoto N, Zack DJ, Semenza GL, et al. Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Visl Sci 1999;40(1):182–89.
   PubMed Web of Science ®Google Scholar
• Lin M, Hu Y, Chen Y, Zhou KK, Jin J, Zhu M, Le YZ, Ge J, Ma JX. Impacts of hypoxia-inducible factor-1 knockout in the retinal pigment epithelium on choroidal neovascularization. Invest Ophthalmol Visl Sci 2012;53(10):6197–206.
   PubMed Web of Science ®Google Scholar
• Chun YS, Yeo EJ, Choi E, Teng CM, Bae JM, Kim MS, Park JW. Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells. Biochem Pharmacol 2001;61(8):947–54.
   PubMed Web of Science ®Google Scholar
• Yeo EJ, Chun YS, Cho YS, Kim J, Lee JC, Kim MS, Park JW. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst 2003;95(7):516–25.
   PubMedGoogle Scholar
• Song SJ, Chung H, Yu HG. Inhibitory effect of YC-1, 3-(5ʹ-hydroxymethyl-2ʹ-furyl)-1-benzylindazole, on experimental choroidal neovascularization in rat. Ophthalmic Res 2008;40(1):35–40.
   PubMed Web of Science ®Google Scholar
• Pan SL, Guh JH, Peng CY, Chang YL, Cheng FC, Chang JH, Kuo SC, Lee FY, Teng CM. A potential role of YC-1 on the inhibition of cytokine release in peripheral blood mononuclear leukocytes and endotoxemic mouse models. Thromb Haemost 2005;93(5):940–48.
   PubMed Web of Science ®Google Scholar
• Miao H, Tao Y, Li XX. Inflammatory cytokines in aqueous humor of patients with choroidal neovascularization. Mol Vis 2012;18:574–80.
   PubMed Web of Science ®Google Scholar
• Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, Rundle AC, Rubio RG, Murahashi WY, Investigators C. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010;117(6):1124–33e1.
   PubMed Web of Science ®Google Scholar
• Shin HJ, Kim HC, Moon JW. Aqueous levels of erythropoietin in acute retinal vein occlusion with macular edema. Int J Ophthalmol 2014;7(3):501–06.
   PubMed Web of Science ®Google Scholar
• Xin X, Rodrigues M, Umapathi M, Kashiwabuchi F, Ma T, Babapoor-Farrokhran S, Wang S, Hu J, Bhutto I, Welsbie DS, et al. Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4. Proc Natl Acad Sci USA 2013;110(36):E3425–34.
   PubMed Web of Science ®Google Scholar
• Miller JW, Adamis AP, Shima DT, D’Amore PA, Moulton RS, O’Reilly MS, Folkman J, Dvorak HF, Brown LF, Berse B, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994;145(3):574–84.
   PubMed Web of Science ®Google Scholar
• Friebe A, Schultz G, Koesling D. Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. Embo J 1996;15(24):6863–68.
   PubMed Web of Science ®Google Scholar
• Yin L, Greenberg K, Hunter JJ, Dalkara D, Kolstad KD, Masella BD, Wolfe R, Visel M, Stone D, Libby RT, et al. Intravitreal injection of AAV2 transduces macaque inner retina. Invest Ophthalmol & Vis Sci 2011;52(5):2775–83.
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Kaufman SC, Palestine AG, Davis MD, Ferris FL 3rd. Macular thickening and visual acuity. Measurement in patients with cystoid macular edema. Ophthalmology. 1987;94(9):1134–39.
   PubMed Web of Science ®Google Scholar
• Bong A, Doughty MJ, Button NF, Mansfield DC. On the relationship between visual acuity and central retinal (macular) thickness after interventions for macular oedema in diabetics: a review. Clin Exp Optom 2016;99(6):491–97.
   PubMed Web of Science ®Google Scholar
• DeNiro M, Alsmadi O, Al-Mohanna F. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis. Exp Eye Res 2009;89(5):700–17.
   PubMed Web of Science ®Google Scholar
• Cho JL, Allanson M, Reeve VE. Hypoxia inducible factor-1alpha contributes to UV radiation-induced inflammation, epidermal hyperplasia and immunosuppression in mice. Photochem Photobiol Sci Off J Eur Photochem Photobiol Sci 2012;11(2):309–17.
   Google Scholar
• DeNiro M, Al-Mohanna FA. Nuclear factor kappa-B signaling is integral to ocular neovascularization in ischemia-independent microenvironment. PLoS One 2014;9(7):e101602.
   PubMed Web of Science ®Google Scholar
• Chan MC, Holt-Martyn JP, Schofield CJ, Ratcliffe PJ. Pharmacological targeting of the HIF hydroxylases–A new field in medicine development. Mol Aspects Med 2016;47-48:54–75.
   PubMed Web of Science ®Google Scholar
• Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009;29(6):313–26.
   PubMed Web of Science ®Google Scholar